FI65441C - Foerfarande foer framstaellning av inklusionskomplex av cyklodextrin och indometacin - Google Patents

Foerfarande foer framstaellning av inklusionskomplex av cyklodextrin och indometacin Download PDF

Info

Publication number
FI65441C
FI65441C FI790198A FI790198A FI65441C FI 65441 C FI65441 C FI 65441C FI 790198 A FI790198 A FI 790198A FI 790198 A FI790198 A FI 790198A FI 65441 C FI65441 C FI 65441C
Authority
FI
Finland
Prior art keywords
indomethacin
complex
cyclodextrin
animals
molar ratio
Prior art date
Application number
FI790198A
Other languages
English (en)
Finnish (fi)
Other versions
FI790198A (fi
FI65441B (fi
Inventor
Jozsef Szejtli
Lajos Szente
Agoston David
Sandor Virag
Gyula Sebestyen
Attila Mandi
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI790198A publication Critical patent/FI790198A/fi
Application granted granted Critical
Publication of FI65441B publication Critical patent/FI65441B/fi
Publication of FI65441C publication Critical patent/FI65441C/fi

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI790198A 1978-01-27 1979-01-22 Foerfarande foer framstaellning av inklusionskomplex av cyklodextrin och indometacin FI65441C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUCI001803 1978-01-27
HU78CI1803A HU176215B (en) 1978-01-27 1978-01-27 Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1

Publications (3)

Publication Number Publication Date
FI790198A FI790198A (fi) 1979-07-28
FI65441B FI65441B (fi) 1984-01-31
FI65441C true FI65441C (fi) 1984-05-10

Family

ID=10994689

Family Applications (1)

Application Number Title Priority Date Filing Date
FI790198A FI65441C (fi) 1978-01-27 1979-01-22 Foerfarande foer framstaellning av inklusionskomplex av cyklodextrin och indometacin

Country Status (23)

Country Link
US (1) US4228160A (it)
JP (1) JPS54117018A (it)
AT (1) AT360554B (it)
AU (1) AU518750B2 (it)
BE (1) BE873725A (it)
CA (1) CA1119115A (it)
CH (1) CH638819A5 (it)
CS (1) CS207742B2 (it)
DD (1) DD141312A1 (it)
DE (1) DE2902297A1 (it)
DK (1) DK154977C (it)
ES (1) ES477181A1 (it)
FI (1) FI65441C (it)
FR (1) FR2415631A1 (it)
GB (1) GB2016499B (it)
HU (1) HU176215B (it)
IL (1) IL56309A (it)
IT (1) IT1118282B (it)
NL (1) NL7808792A (it)
NO (1) NO146637C (it)
PL (1) PL117208B1 (it)
SE (1) SE445353B (it)
SU (1) SU915807A3 (it)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606074A (en) * 1946-08-21 1952-08-05 Edward H Ackermann Air distributing nozzle
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
DE2947742C2 (de) * 1979-11-27 1986-04-03 Koch, Jürgen, Dr., 2000 Hamburg Arzneimittel, enthaltend β-Cyclodextrin
HU184066B (en) * 1979-12-28 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Plant growth regulating substance and process for preparing such compound
HU181733B (en) * 1980-08-07 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing sorbents containing cyclodextrin on cellulose base
HU182217B (en) * 1980-10-17 1983-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing inclusive complexes of cyclodextrines and strong inorganic oxyacids
JPS5830032B2 (ja) * 1981-02-18 1983-06-27 呉羽化学工業株式会社 ビフイダス菌の増殖剤
HU183430B (en) * 1981-05-12 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride
JPS58177949A (ja) * 1982-04-12 1983-10-18 Takeda Chem Ind Ltd ランカシジン群抗生物質包接化合物
US4425336A (en) 1982-05-24 1984-01-10 Key Pharmaceuticals, Inc. 3,4-Dihydroxy-N-[3-(4-dihydroxyphenyl)-1-methyl-n-propyl]-beta-phenethylamine cyclodextrin complexes
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
HU190818B (en) * 1982-11-09 1986-11-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing complexes of piperonyl-butoxide-cyclodextrin
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
US4502930A (en) * 1983-06-27 1985-03-05 Agency Of Industrial Science & Technology Method for manufacture of 7-substituted quadricyclene-cyclodextrin inclusion compound
JPS6025967A (ja) * 1983-07-21 1985-02-08 Eisai Co Ltd トリパミド包接化合物
US4675395A (en) * 1984-03-14 1987-06-23 Seiwa Technological Laboratories Limited Cyclodextrin inclusion compound and process for its preparation
JPS60202115A (ja) * 1984-03-27 1985-10-12 Ichiro Shibauchi エポキシ樹脂用硬化剤
DE3427787A1 (de) * 1984-07-27 1986-01-30 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Wirkstoffkomplexe von 5-methoxy-2((4-methoxy-3,5-dimethyl-2-pyridyl) methylsulfinyl)-1h-benzimidazol mit cyclodextrinen, deren herstellung und arzneimittel
YU43290B (en) * 1986-11-13 1989-06-30 Lek Tovarna Farmacevtskih Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
US4885275A (en) * 1987-10-15 1989-12-05 Eli Lilly And Company Vancomycin-HCL solutions and the lyophilization thereof
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
SI8810082A8 (en) * 1988-01-18 1995-12-31 Lek Tovarna Farmacevtskih Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine
DE3809808A1 (de) * 1988-03-23 1989-10-05 Hexal Pharma Gmbh & Co Kg Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
CA2013485C (en) * 1990-03-06 1997-04-22 John Michael Gardlik Solid consumer product compositions containing small particle cyclodextrin complexes
US5246611A (en) * 1990-05-09 1993-09-21 The Procter & Gamble Company Non-destructive carriers for cyclodextrin complexes
US5384186A (en) * 1990-05-09 1995-01-24 The Proctor & Gamble Company Non-destructive carriers for cyclodextrin complexes
US5139687A (en) * 1990-05-09 1992-08-18 The Proctor & Gamble Company Non-destructive carriers for cyclodextrin complexes
JPH07583B2 (ja) * 1990-11-21 1995-01-11 北海道糖業株式会社 水溶性五環性トリテルペン包接化合物及びその製造方法並びにそれを利用した食品、飲料、口腔用組成物
US5321014A (en) * 1991-06-28 1994-06-14 The United States Of America As Represented By The Department Of Health And Human Services Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
US20040014695A1 (en) * 1992-06-19 2004-01-22 Supergen, Inc. Pharmaceutical formulation
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
US5403828A (en) * 1992-08-13 1995-04-04 American Maize-Products Company Purification of cyclodextrin complexes
CA2190598A1 (en) * 1994-05-27 1995-12-07 Lawrence John Penkler Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US5744154A (en) * 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
US6287603B1 (en) * 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
KR100473716B1 (ko) * 2002-03-27 2005-03-08 주식회사 참 존 7-디하이드로콜레스테롤 및 사이클로덱스트린의 포접복합체, 이를 포함하는 화장료 조성물 및7-디하이드로콜레스테롤의 안정화방법
CN101223183A (zh) * 2005-06-13 2008-07-16 嘉吉公司 环糊精包合复合物及其制备方法
BRPI0612032A2 (pt) * 2005-06-13 2010-10-13 Cargill Inc complexos de inclusão de ciclodextrina e métodos de preparação dos mesmos
US20070009531A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
US20070010478A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
US20070010487A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010485A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010486A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
KR20090016702A (ko) * 2006-06-13 2009-02-17 카아길, 인코포레이팃드 큰 입자 시클로덱스트린 포접 착물 및 이의 제조 방법
WO2008083213A2 (en) * 2006-12-27 2008-07-10 Cargill, Incorporated Stabilisation by preparing cyclodextrin inclusion complexes
US20080283693A1 (en) * 2007-05-15 2008-11-20 Evans Michael J F Propulsion apparatus and system
WO2009144927A1 (ja) * 2008-05-27 2009-12-03 富士フイルム株式会社 薬剤含有組成物
FR2989001B1 (fr) * 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
ES2878580T3 (es) 2016-02-04 2021-11-19 Czap Res And Development Llc Vehículos de complejos de inclusión de ciclodextrina estratificados y de liberación controlada
CN107184989B (zh) * 2017-05-18 2020-09-08 宁夏蓝博思化学技术有限公司 甘草素-环糊精或环糊精衍生物包合物及组合物及制备方法及用途
CN107158403B (zh) * 2017-05-18 2020-09-08 宁夏蓝博思化学技术有限公司 异甘草素-环糊精或环糊精衍生物包合物及组合物及制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2959580A (en) * 1956-10-17 1960-11-08 Univ Minnesota Formation of inclusion compounds
US3061444A (en) * 1960-10-07 1962-10-30 Gen Foods Corp Inclusion compounds incorporating edible juice constituents
FI41158B (it) 1961-03-22 1969-06-02 Merck & Co Inc
US4054736A (en) * 1970-06-10 1977-10-18 Ono Pharmaceutical Co., Ltd. Clathrate compounds of prostaglandins or their analogues with cyclodextrin

Also Published As

Publication number Publication date
SE7900479L (sv) 1979-07-28
PL117208B1 (en) 1981-07-31
CS207742B2 (en) 1981-08-31
GB2016499A (en) 1979-09-26
US4228160A (en) 1980-10-14
IT1118282B (it) 1986-02-24
AU518750B2 (en) 1981-10-15
CA1119115A (en) 1982-03-02
SU915807A3 (en) 1982-03-23
FR2415631A1 (fr) 1979-08-24
IT7967050A0 (it) 1979-01-11
ATA59179A (de) 1980-06-15
JPS54117018A (en) 1979-09-11
DE2902297A1 (de) 1979-08-02
IL56309A (en) 1981-09-13
FR2415631B1 (it) 1981-12-24
FI790198A (fi) 1979-07-28
PL213015A1 (pl) 1979-12-17
HU176215B (en) 1981-01-28
NO146637C (no) 1982-11-10
ES477181A1 (es) 1979-10-16
DD141312A1 (de) 1980-04-23
NL7808792A (nl) 1979-07-31
NO790261L (no) 1979-07-30
NO146637B (no) 1982-08-02
GB2016499B (en) 1982-07-28
AT360554B (de) 1981-01-26
BE873725A (fr) 1979-05-16
DK35079A (da) 1979-07-28
DK154977B (da) 1989-01-16
DE2902297C2 (it) 1989-02-09
DK154977C (da) 1989-06-12
CH638819A5 (de) 1983-10-14
AU4367179A (en) 1979-08-02
FI65441B (fi) 1984-01-31
SE445353B (sv) 1986-06-16

Similar Documents

Publication Publication Date Title
FI65441C (fi) Foerfarande foer framstaellning av inklusionskomplex av cyklodextrin och indometacin
FI67390B (fi) Foerfarande foer framstaellning av en inklusionskomplex av n-(1-fenyletyl)-3,3-difenylpropylamin eller dess hydroklorid me cyklodextrin
JPH10504347A (ja) 水溶性ポリエン複合体
PT91563A (pt) Process for the preparation of cyclodextrin derivatives and inclusion complexes containing cyclodextrin derivatives
HU188657B (en) Process for the preparation of anticoagulant mycopolysaccharides
US5159069A (en) Sulfated tannins and their salts
JPS5952164B2 (ja) グルコサミノグルカン誘導体、その製造法およびそれを有効成分とする抗脂肪血症剤
EP0422497A2 (en) Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them
JPH05125102A (ja) 市販カラゲニン類の精製方法
AU609999B2 (en) Bismuth (phosph/sulf)ated saccharides
RU2110265C1 (ru) Средство для лечения или профилактики заболеваний, вызванных нехваткой йода
US5300493A (en) Ulcer treatment using choline esters of polysaccharides
JPH10218769A (ja) 抗潰瘍剤
US4009264A (en) Complexes of polysaccharides or derivatives thereof with reduced glutathione and process for preparing said complexes
US4707472A (en) Cycloartenol ferulate/cyclodextrin complex
KR950004705B1 (ko) 시클로덱스트린 유도체와 n-에톡시카르보닐-3-모르폴리노-시드노니민 또는 그 염들에 의해 형성된 함유복합체 및 그 제조방법과 이들을 함유하는 약제학적 조성물
US3870792A (en) Certain dihydrophthalizines for treating hemorrhage and thrombosis
JPS604189B2 (ja) 抗菌剤およびその製法
US4242330A (en) Derivative of aspirin
RU2128664C1 (ru) СОЕДИНЕНИЕ ВКЛЮЧЕНИЯ 9-(2-ОКСИЭТОКСИМЕТИЛ)ГУАНИНА С β-ЦИКЛОДЕКСТРИНОМ, ОБЛАДАЮЩЕЕ АНТИГЕРПЕСНОЙ АКТИВНОСТЬЮ
FR2499409A1 (fr) Agent therapeutique a base d'une protease acide, pour le traitement des troubles allergiques, des maladies avec immunocomplexe et des tumeurs
US4918175A (en) Bismuth (phosph/sulf)ated saccharides
JPH1129465A (ja) 抗潰瘍剤
JPH0372490A (ja) 硫酸化タンニン及びその塩
JP3048628B2 (ja) 還元ヘキサ―ｎ―アセチル―キトヘキサオースを有効成分とする抗腫瘍剤

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CHINOIN GYOGUSZER ES VEGYESZETI TERMEKEK